Michael Chambers, Founder and CEO, Among 100 Most Intriguing Entrepreneurs at 2018 Builders + Innovators Summit
Goldman Sachs (NYSE:GS) is recognizing Aldevron CEO and Founder Michael Chambers as one of the 100 Most Intriguing Entrepreneurs at the 2018 Builders + Innovators Summit in Santa Barbara, California.Goldman Sachs selected Chambers as one of 100 entrepreneurs from multiple industries to be honored at the three-day event. Founded in 1998, Aldevron supplies plasmid DNA and gene editing enzymes to biopharmaceutical researchers developing advanced gene-based medicines. Aldevron also provides recombinant biological products for veterinary and agriculture applications.
“My colleagues and I are honored by this award,” said Michael. “It is the highest privilege to serve our clients who are leading a biotech revolution that is curing disease and helping to feed the world.” He added that Aldevron’s mission has remained unchanged for 20 years: to improve lives through innovative partnerships and scientific excellence.
Aldevron products are key components in clinical and commercial gene therapies. The company has locations in North Dakota, Wisconsin, and Germany, and has grown organically and through acquisition. Aldevron recently opened the first building on its new 10-acre campus in Fargo, North Dakota. The 70,000 square-foot structure is the largest plasmid DNA GMP manufacturing facility in the world.
“A dynamic economy depends on dynamic entrepreneurs who disrupt industries and occasionally give birth to entirely new sectors,” said David M. Solomon, Chief Executive Officer of Goldman Sachs. “The purpose of Builders + Innovators is to support emerging leaders in their quests to innovate faster in order to grow their ideas. We are pleased to recognize Michael Chambers as one of the most intriguing entrepreneurs of 2018.”
For more than 150 years, Goldman Sachs has been advising and financing entrepreneurs as they launch and grow their businesses. In addition to honoring 100 entrepreneurs, the Summit consists of general sessions and clinics led by seasoned entrepreneurs, academics and business leaders as well as resident scholars.
Aldevron serves the biotechnology industry with custom production of nucleic acids, proteins, and antibodies. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from discovery research to clinical trials to commercial applications. These products are critical raw materials and key components in commercially available drugs and medical devices. Aldevron specializes in GMP manufacturing and is known for inventing the GMP-SourceTM quality system. Company headquarters are in Fargo, North Dakota, with additional facilities in Madison, Wisconsin, and Freiburg, Germany.